1. Home
  2. NVAX vs PRG Comparison

NVAX vs PRG Comparison

Compare NVAX & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • PRG
  • Stock Information
  • Founded
  • NVAX 1987
  • PRG 2020
  • Country
  • NVAX United States
  • PRG United States
  • Employees
  • NVAX N/A
  • PRG N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • PRG Diversified Commercial Services
  • Sector
  • NVAX Health Care
  • PRG Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • PRG Nasdaq
  • Market Cap
  • NVAX 1.3B
  • PRG 1.1B
  • IPO Year
  • NVAX 1995
  • PRG N/A
  • Fundamental
  • Price
  • NVAX $6.00
  • PRG $26.24
  • Analyst Decision
  • NVAX Buy
  • PRG Buy
  • Analyst Count
  • NVAX 6
  • PRG 6
  • Target Price
  • NVAX $17.83
  • PRG $46.80
  • AVG Volume (30 Days)
  • NVAX 6.0M
  • PRG 497.3K
  • Earning Date
  • NVAX 05-09-2025
  • PRG 04-23-2025
  • Dividend Yield
  • NVAX N/A
  • PRG 1.98%
  • EPS Growth
  • NVAX N/A
  • PRG 52.01
  • EPS
  • NVAX N/A
  • PRG 4.53
  • Revenue
  • NVAX $682,162,000.00
  • PRG $2,463,496,000.00
  • Revenue This Year
  • NVAX $1.07
  • PRG $4.49
  • Revenue Next Year
  • NVAX N/A
  • PRG $4.70
  • P/E Ratio
  • NVAX N/A
  • PRG $5.79
  • Revenue Growth
  • NVAX N/A
  • PRG 2.29
  • 52 Week Low
  • NVAX $3.81
  • PRG $23.50
  • 52 Week High
  • NVAX $23.86
  • PRG $50.28
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 41.41
  • PRG 45.70
  • Support Level
  • NVAX $5.01
  • PRG $25.17
  • Resistance Level
  • NVAX $6.58
  • PRG $25.88
  • Average True Range (ATR)
  • NVAX 0.65
  • PRG 1.43
  • MACD
  • NVAX 0.02
  • PRG 0.28
  • Stochastic Oscillator
  • NVAX 50.25
  • PRG 57.20

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About PRG PROG Holdings Inc.

PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.

Share on Social Networks: